Fortress Biotech Inc (FBIO)
1.465
+0.04
(+2.45%)
USD |
NASDAQ |
Nov 18, 15:20
Fortress Biotech Price: 1.465 for Nov. 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 15, 2024 | 1.55 | 1.57 | 1.41 | 1.43 | 817580.0 |
| Nov 14, 2024 | 1.63 | 1.635 | 1.56 | 1.57 | 318680.0 |
| Nov 13, 2024 | 1.72 | 1.74 | 1.63 | 1.65 | 434821.0 |
| Nov 12, 2024 | 1.75 | 1.75 | 1.66 | 1.70 | 365590.0 |
| Nov 11, 2024 | 1.73 | 1.79 | 1.71 | 1.76 | 278651.0 |
| Nov 08, 2024 | 1.71 | 1.76 | 1.66 | 1.71 | 313582.0 |
| Nov 07, 2024 | 1.77 | 1.80 | 1.71 | 1.72 | 240256.0 |
| Nov 06, 2024 | 1.74 | 1.815 | 1.685 | 1.76 | 483813.0 |
| Nov 05, 2024 | 1.70 | 1.77 | 1.55 | 1.765 | 1.154M |
| Nov 04, 2024 | 1.99 | 1.99 | 1.70 | 1.73 | 1.672M |
| Nov 01, 2024 | 1.93 | 1.955 | 1.86 | 1.90 | 786103.0 |
| Oct 31, 2024 | 1.91 | 1.945 | 1.86 | 1.90 | 388179.0 |
| Oct 30, 2024 | 2.03 | 2.07 | 1.92 | 1.94 | 474849.0 |
| Oct 29, 2024 | 2.02 | 2.10 | 1.94 | 2.02 | 881476.0 |
| Oct 28, 2024 | 1.94 | 2.04 | 1.91 | 2.02 | 1.096M |
| Oct 25, 2024 | 1.73 | 1.88 | 1.71 | 1.85 | 761291.0 |
| Oct 24, 2024 | 1.77 | 1.81 | 1.72 | 1.73 | 265831.0 |
| Oct 23, 2024 | 1.81 | 1.85 | 1.755 | 1.78 | 299447.0 |
| Oct 22, 2024 | 1.79 | 1.85 | 1.74 | 1.81 | 651564.0 |
| Oct 21, 2024 | 1.80 | 1.82 | 1.74 | 1.78 | 415152.0 |
| Oct 18, 2024 | 1.85 | 1.87 | 1.725 | 1.83 | 632910.0 |
| Oct 17, 2024 | 1.78 | 1.85 | 1.74 | 1.81 | 676672.0 |
| Oct 16, 2024 | 1.73 | 1.76 | 1.72 | 1.75 | 585788.0 |
| Oct 15, 2024 | 1.69 | 1.73 | 1.68 | 1.72 | 283647.0 |
| Oct 14, 2024 | 1.65 | 1.700 | 1.64 | 1.68 | 481811.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.31
Minimum
Nov 10 2023
82.20
Maximum
Apr 12 2021
24.80
Average
16.20
Median
Apr 14 2022
Price Benchmarks
| Journey Medical Corp | 5.09 |
| Checkpoint Therapeutics Inc | 3.28 |
| Avenue Therapeutics Inc | 1.94 |
| Mustang Bio Inc | 0.2189 |
| NovaBay Pharmaceuticals Inc | 0.6995 |
Price Related Metrics
| PS Ratio | 0.1624 |
| Price to Book Value | 1.870 |
| Earnings Yield | -917.8% |
| Market Cap | 33.42M |